Galena Biopharma CEO Mark Ahn Steps Down; Names Mark Schwartz Replacement

(RTTNews) - Galena Biopharma Inc. (GALE) Thursday said Mark Ahn, its President and Chief Executive Officer, has resigned from the company to pursue other goals. Mark Schwartz will take over the position, effective immediately.

Previously, Schwartz was Galena's Executive Vice President and Chief Operating Officer. He has over 30 years of experience in the biotechnology and life science industry. Before joining Galena, he had served in the roles of President and Chief Executive at Apthera Inc. and at Bayhill Therapeutics. He was also the President and CEO of Calyx Therapeutics, which expanded significantly, and completed key Phase 1 and Phase 2 international clinical trials of novel anti-inflammatory compounds during his tenure.